A group of 8 Member States, represented by Latvia, have expressed their concerns about the rigid reduction targets in the draft Sustainable Use Regulation.
The Polish competent authority released its travel report on the SCoPAFF Legislation meeting of 13-14.10.2022
The Polish competent authority published a report on the SCoPAFF Legislation meeting of 14-15.07.2022.
On 24.05.2022 EFSA opened a consultation on the RAR for MCPA.
The Polish competent authorities published their report on the SCoPAFF Legislation meeting of 30-31 March 2022.
On 18.02.2022 The Polish competent authority published its report on the SCoPAFF Legislation meeting of 27-28.01.2022.
The Polish competent authority published its report of the SCoPAFF Legislation meeting of 05-06.07.2021.
The Polish competent authority published a report on the SCoPAFF meeting of 19-20.05.2021.
A report from the Polish delegation to the SCoPAFF Legislation meeting of 24-25 March 2021 was published.
Commissioner Kyriakides answered a question from MEP Robert Biedroń (S&D) on authorisations for neonics in Poland.
On 05.02.2021 the Polish competent authority published its report on the SCoPAFF Legislation meeting of 03-04.12.2020.
A question from MEP Robert Biedroń (S&D) to the Commission was published, regarding emergency authorisations for neonics in Poland.
1,4-dimethylnaphthalene, 6-benzyladenine, acetic acid, aluminium ammonium sulphate, aluminium sulphate, diflubenzuron, fat distillation residues, fludioxonil, flufenoxuron, Gliocladium catenulatum...
amidosulfuron, clomazone, daminozide , deltamethrin, deltamethrin, emamectin benzoate, fluoxastrobin, folpet, fosetyl, gibberellic acid, gibberellin, lenacil, mepiquat chloride, meptyldinocap...
Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, carbendazim, clodinafop, clothianidin, ethephon, flutolanil, flutriafol, imidacloprid, limestone , neonics, Paecilomyces...
On 03.11.2020 the Commission answered a written question from MEP Robert Biedroń (S&D), who wanted to know if the Commission was aware of emergency authorisations for neonics in Poland, and what...
The European Parliament sent another two written questions to the Commission, about emergency authorisations and on the use of neonics in Poland.
EFSA notified a delay in the renewal process of benthiavalicarb, metiram, and dimethomorph, due to Art. 4.7 reviews